Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon‐β via their tumor‐tropic effect in cellular and xenograft mouse models

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Oncology

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molonc.2013.01.004PMID 23403306PMCID PMC5528496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon‐β via their tumor‐tropic effect in cellular and xenograft mouse models

  2013cited by this paper
• Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use

  2011cited by this paper
• Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects.

  2011cited by this paper
• Potential tumor-tropic effect of genetically engineered stem cells expressing suicide enzymes to selectively target invasive cancer in animal models.

  2011cited by this paper
• Neural Stem Cell-based Gene Therapy for Brain Tumors

  2011cited by this paper
• Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.

  2011cited by this paper
• Treatment of metastatic colorectal cancer.

  2011cited by this paper
• Influence of the prodrugs 5‐fluorocytosine and CPT‐11 on ovarian cancer cells using genetically engineered stem cells: tumor‐tropic potential and inhibition of ovarian cancer cell growth

  2010cited by this paper
• Cytosine deaminase‐producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model

  2009cited by this paper
• Stem and progenitor cell-mediated tumor selective gene therapy

  2008cited by this paper
• Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas

  2008cited by this paper
• Prodrug cancer gene therapy.

  2008cited by this paper
• Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia

  2008cited by this paper
• Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model

  2008cited by this paper
• Interferon‐α and 5‐fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules

  2007cited by this paper
• Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma

  2007cited by this paper
• Genetically engineered human neural stem cells for brain repair in neurological diseases.

  2007cited by this paper
• Genetically engineered stem cells for therapeutic gene delivery.

  2007cited by this paper
• Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.

  2007cited by this paper
• Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression

  2006cited by this paper
• A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.

  2006cited by this paper
• Stem Cells and Metastatic Cancer: Fatal Attraction?

  2006cited by this paper
• Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.

  2006cited by this paper
• Gene therapy: can neural stem cells deliver?

  2006cited by this paper
• Optimal treatment of metastatic colorectal cancer

  2006cited by this paper
• Development of a Tumor-Selective Approach to Treat Metastatic Cancer

  2006cited by this paper
• Biology of colorectal liver metastases: A review

  2006cited by this paper
• Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor.

  2005cited by this paper
• Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases

  2005cited by this paper
• Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

  2005cited by this paper
• The endocannabinoid system drives neural progenitor proliferation

  2005cited by this paper
• Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

  2004cited by this paper
• IFN-β Induces Caspase-Mediated Apoptosis by Disrupting Mitochondria in Human Advanced Stage Colon Cancer Cell Lines

  2004cited by this paper
• Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.

  2004cited by this paper
• Human neural stem cells genetically modified for brain repair in neurological disorders

  2004cited by this paper
• IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines.

  2004cited by this paper
• Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.

  2004cited by this paper
• Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.

  2004cited by this paper
• Tissue-specific promoters for cancer gene therapy

  2004cited by this paper
• Intravascular Delivery of Neural Stem Cell Lines to Target Intracranial and Extracranial Tumors of Neural and Non-Neural Origin

  2003cited by this paper
• A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development

  2003cited by this paper
• Current Progress in Suicide Gene Therapy for Cancer

  2002cited by this paper
• Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.

  2002cited by this paper
• Production of immortalized human neural crest stem cells.

  2002cited by this paper
• In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase

  2001cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report.

  1998cited by this paper
• In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.

  1997cited by this paper
• Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.

  1997cited by this paper
• Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.

  1997cited by this paper
• In Vivo Adenovirus-Mediated Gene Transfer of the Escherichia coli Cytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

  1995cited by this paper
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

  1994cited by this paper
• Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

  1992cited by this paper
• CD

  1992cited by this paper
• Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

  1986cited by this paper
• Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase.

  1961cited by this paper
• Studies on fluorinated pyrimidines. II. Effects on transplanted tumors.

  1958cited by this paper

• Thermoresponsive Graft Copolymers of N‑Isopropylacrylamide and Hyperbranched Polyglycerol as Thermally Induced Drug Delivery and Release Nanoformulation Systems for Curcumin with High Colloidal Stability and Enhanced Anticancer Effect

  2026cites this paper
• Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing

  2024cites this paper
• Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis

  2024cites this paper
• Evaluating the potential of off-the-shelf engineered mesenchymal stem cells for targeted Hepatocellular Carcinoma treatment: A multisite proof-of-concept study.

  2024cites this paper
• Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

  2023cites this paper
• Nerves in gastrointestinal cancer: from mechanism to modulations

  2022cites this paper
• Establishment of an In Vivo Xenograft Mouse Model of a Subcutaneous Submillimeter HT-29 Tumor Formed from a Single Spheroid Transplanted Using Radiation-Crosslinked Gelatin Hydrogel Microwell

  2021influential citation
• A promising therapeutic strategy for metastatic gestational trophoblastic disease: Engineered anticancer gene-expressing stem cells to selectively target choriocarcinoma.

  2019cites this paper
• Coelomic fluid of Lumbricus rubellus enhances anti-prolioniferative effect of 5-fluorouracil by modulating focal adhesion kinase express and IL-1β of colorectal cancer in mice

  2019cites this paper
• The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models.

  2018cites this paper
• A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models

  2018cites this paper
• Stem Cells Treatment to Combat Cancer and Genetic Disease: From Stem Cell Therapy to Gene-Editing Correction

  2018cites this paper
• Effects of cigarette smoke extracts on cell cycle, cell migration and endocrine activity in human placental cells.

  2017cites this paper
• Role of Type I and II Interferons in Colorectal Cancer and Melanoma

  2017cites this paper
• Stem cells in cancer therapy: opportunities and challenges

  2017cites this paper
• Cancer-Specific Inhibitory Effects of Genetically Engineered Stem Cells Expressing Cytosine Deaminase and Interferon-β Against Choriocarcinoma in Xenografted Metastatic Mouse Models

  2017cites this paper
• Cigarette smoke extracts induced the colon cancer migration via regulating epithelial mesenchymal transition and metastatic genes in human colon cancer cells

  2017cites this paper
• Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma (Review).

  2016cites this paper
• Anti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter

  2016cites this paper
• Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node–Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models

  2016cites this paper
• Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.

  2015cites this paper
• BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs

  2015cites this paper
• Gene therapy strategies using engineered stem cells for treating gynecologic and breast cancer patients (Review).

  2015cites this paper
• Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer

  2015cites this paper
• Comparison of site-specific PEGylations of the N-terminus of interferon beta-1b: selectivity, efficiency, and in vivo/vitro activity.

  2014cites this paper
• Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice

  2014cites this paper
• Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells

  2013cites this paper
• Development and application of neural stem cells for treating various human neurological diseases in animal models

  2013cites this paper
• Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon‐β via their tumor‐tropic effect in cellular and xenograft mouse models

  2013cites this paper